Clinical Trial Update: Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating SST-0225 topical ibuprofen cream for Delayed Onset Muscle Soreness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed-onset Muscle Soreness

Drugs mentioned

• SST-0225 topical ibuprofen cream (ibuprofen)

Snippet

Sponsor: Strategic Science & Technologies, LLC | Conditions: Delayed Onset Muscle Soreness, DOMS | Phase 3 | Status: COMPLETED